The Recall Desk
Agency classClass IIOur severity:Severity pendingFDA (Drugs)·D-0104-2027·Announced 2026-11-04

MENTHOL AND METHYL SALICYLATE (ELECTRIC MEDICATED BALM ULTRA STRENGTH)

CGMP Deviations — MENTHOL AND METHYL SALICYLATE (ELECTRIC MEDICATED BALM ULTRA STRENGTH)

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

Severity not yet assessed

We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.

Plain-English summary

CGMP Deviations

The recalled product

Product
MENTHOL AND METHYL SALICYLATE (ELECTRIC MEDICATED BALM ULTRA STRENGTH)
Brand
MENTHOL AND METHYL SALICYLATE
Affected units
171,120

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (6)

  • Lot: a)23FEBU7001-019
  • Exp. Date: October 2028
  • 24FEBU7001-020
  • Exp. Date: November 2029. b) 23FEBU1001-9
  • 24FEBU1001-004
  • Exp. Date: November 2029.

Distribution

Distributed nationwide across the United States.